Trial intelligence / Profile preview

Immunogenicity and Safety of Tenivac vs Decavac in Adults and Adolescents

NCT00601835Phase 4Completed

Sponsor
Sanofi
Start
May 2004
Primary completion
Jul 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of tetanus toxoid vaccine adsorbed in diphtheria, Tetanus, sponsored by Sanofi. Started May 2004; status: completed.

02

Drugs

tetanus toxoid vaccine adsorbed
03

Conditions

diphtheriaTetanus

Beyond the preview

Go deeper on NCT00601835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00601835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call